Hyperhomocysteinemia associates with small vessel disease more closely than large vessel disease

International Journal of Medical Sciences

Volumn 10, Issue 4, 2013, Pages 408-412

  Feng, Chao ^a   Bai, Xue ^a   Xu, Yu ^a   Hua, Ting ^a   Huang, Jing ^a   Liu, Xue Yuan ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Homocysteine; Hyperhomocysteinemia; Large vessel disease; Small vessel disease

Indexed keywords

HOMOCYSTEINE;

ADULT; AGE DISTRIBUTION; AGED; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRAIN ATHEROSCLEROSIS; BRAIN INFARCTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; INDEPENDENT VARIABLE; LARGE VESSEL DISEASE; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SEX DIFFERENCE; SMALL VESSEL DISEASE; VASCULAR DISEASE;

HOMOCYSTEINE.; HYPERHOMOCYSTEINEMIA; LARGE VESSEL DISEASE; SMALL VESSEL DISEASE;

AGED; BRAIN ISCHEMIA; CEREBRAL ARTERIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK FACTORS; STROKE;

EID: 84874774233     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5272     Document Type: Article

References (32)

1. Sen U, Mishra PK, Tyagi N, Tyagi SC. Homocysteine to hydrogen sulfide or hypertension. Cell Biochem Biophys 2010;57:49-58.
2. Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function. Curr Drug Metab 2005;6:27-36.
3. Abahji TN, Nill L, Ide N, Keller C, Hoffmann U, Weiss N. Acute Hyperhomocysteinemia Induces Microvascular and Macrovascular Endothelial Dysfunction. Archives of Medical Research 2007;38:411-416.
4. Wierzbicki AS. Homocysteine and cardiovascular disease: a review of the evidence. Diabetes & vascular disease research: official journal of the International Society of Diabetes and Vascular Disease 2007:143.
5. Iso H. Serum Total Homocysteine Concentrations and Risk of Stroke and Its Subtypes in Japanese. Circulation 2004;109:2766-2772.
6. Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI. Association Between High Homocyst(e)ine and Ischemic Stroke due to Large- and Small-Artery Disease but Not Other Etiologic Subtypes of Ischemic Stroke. Stroke 2000;31:1069-1075.
7. Perini F, Galloni E, Bolgan I, et al. Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: stronger association with small artery disease. Neurological Sciences 2005;26:310-318.
8. Khan U, Crossley C, Kalra L, et al. Homocysteine and Its Relationship to Stroke Subtypes in a UK Black Population: The South London Ethnicity and Stroke Study. Stroke 2008;39:2943-2949.
9. Tan NCK. Hyperhomocyst(e)inemia and Risk of Ischemic Stroke Among Young Asian Adults. Stroke 2002;33:1956-1962.
10. Parnetti L, Caso V, Santucci A, et al. Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Neurological Sciences 2004;25:13-17.
11. Lee SH, Bae HJ, Yoon BW, Kim H, Kim DE, Roh JK. Low Concentration of Serum Total Cholesterol Is Associated With Multifocal Signal Loss Lesions on Gradient-Echo Magnetic Resonance Imaging: Analysis of Risk Factors for Multifocal Signal Loss Lesions. Stroke 2002;33:2845-2849.
12. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689-701.
13. Murat Sumer M, Erturk O. Ischemic stroke subtypes: risk factors, functional outcome and recurrence. Neurol Sci 2002;22:449-454.
14. Kloppenborg RP, Nederkoorn PJ, van der Graaf Y, Geerlings MI. Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study. Atherosclerosis 2011;216:461-466.
15. Jung KW, Shon Y-M, Yang DW, Kim BS, Cho AH. Coexisting Carotid Atherosclerosis in Patients with Intracranial Small- or Large-Vessel Disease. Journal of Clinical Neurology 2012;8:104.
16. Moran C, Phan TG, Srikanth VK. Cerebral small vessel disease: a review of clinical, radiological, and histopathological phenotypes. Int J Stroke 2012;7:36-46.
17. Xiong YY, Mok V. Age-related white matter changes. J Aging Res 2011;2011:617927.
18. Franz Fazekas JBC, Abass Alavi, Howard I. Hurtig, Robert A. Zimmerman. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR 1987;149:351-356.
19. Zhu YC, Dufouil C, Tzourio C, Chabriat H. Silent brain infarcts: a review of MRI diagnostic criteria. Stroke 2011;42:1140-1145.
20. Lien L-M, Hsieh Y-C, Bai C-H, et al. Association of blood active matrix metalloproteinase-3 with carotid plaque score from a community population in Taiwan. Atherosclerosis 2010;212:595-600.
21. R. Clarke LD, K. Robinson, E. Naughten, S. Cahalane, B. Fowler, I. Garham. Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease. NEJM 1991; 324:1149-1155.
22. Knottnerus ILH, Ten Cate H, Lodder J, Kessels F, van Oostenbrugge RJ. Endothelial Dysfunction in Lacunar Stroke: A Systematic Review. Cerebrovascular Diseases 2009;27:519-526.
23. Landmesser U. Endothelial Function: A Critical Determinant in Atherosclerosis? Circulation 2004;109:27-33.
24. Markus HS. Genes, endothelial function and cerebral small vessel disease in man. Experimental Physiology 2007;93:121-127.
25. Stevenson SF, Doubal FN, Shuler K, Wardlaw JM. A Systematic Review of Dynamic Cerebral and Peripheral Endothelial Function in Lacunar Stroke Versus Controls. Stroke 2010;41:e434-e442.
26. Öncel Ç, Demir S, Güler S, Cenikli U, Tabak E, Kiroǧlu Y. Association between cholesterols, homocysteine and silent brain infarcts. Internal Medicine Journal 2009;39:150-155.
27. Tseng Y-L, Chang Y-Y, Liu J-S, Su C-S, Lai S-L, Lan M-Y. Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients. Journal of the Neurological Sciences 2009;284:36-39.
28. Censori B, Partziguian T, Manara O, Poloni M. Plasma homocysteine and severe white matter disease. Neurological Sciences 2007;28:259-263.
29. Khan U, Porteous L, Hassan A, Markus HS. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry 2007;78:702-706.
30. Vermeer SE, Longstreth WT, Jr., Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007;6:611-619.
31. Potter K, Hankey GJ, Green DJ, Eikelboom J, Jamrozik K, Arnolda LF. The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis. BMC Cardiovascular Disorders 2008;8:24.
32. Mager A, Orvin K, Koren-Morag N, et al. Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease. Am J Cardiol 2009;104:745-749.